peptides
Does BPC-157 heal tendon and ligament injuries in humans?
No strong human evidence shows that BPC-157 heals tendon or ligament injuries.
Evidence:Mostly lab/animalRisk:High risk
Regulatory calendar
Living watchpoints for regulatory events that longevity marketers may overread, misread or quote without context.
Evidence:Regulatory watchRisk:Moderate riskStatus:Status unclear
Last checked: Jun 27, 2026
Simple answer
Regulatory events are signals to watch, not proof that a product or intervention is approved for longevity. The July 23-24, 2026 FDA peptide meeting is a compounding-review event, not approval for anti-aging claims.
| Date | Event | Compounds | Status | Source |
|---|---|---|---|---|
| Jul 23, 2026 America/New_York | FDA Pharmacy Compounding Advisory Committee peptide review This is not FDA approval for anti-aging, fitness, recovery or OTC use. It is a compounding-review event for specified uses described in the Federal Register notice for FDA docket FDA-2025-N-6895. Related tracker → | BPC-157, KPV, TB-500, MOTs-C, Emideltide / DSIP, Semax, Epitalon | Upcoming | FDA |
July 23-24, 2026 FDA peptide meeting: Internet claim vs FDA-reviewed use
This FDA Pharmacy Compounding Advisory Committee meeting reviews specified compounding questions. Internet claims and FDA-reviewed uses are not the same thing, and review for one use does not validate broader recovery, fitness, anti-aging or biohacking claims.
- BPC-157
- ulcerative colitis
- KPV
- wound healing and inflammatory conditions
- TB-500
- wound healing
- MOTs-C
- obesity and osteoporosis
- Emideltide / DSIP
- opioid withdrawal, chronic insomnia, narcolepsy
- Semax
- cerebral ischemia, migraine, trigeminal neuralgia
- Epitalon
- insomnia
Internet claim vs regulatory question
Internet claim
BPC-157 heals tendons and gym injuries.
FDA-reviewed use
BPC-157: ulcerative colitis.
Why the mismatch matters
A regulatory review for one specified use does not validate broader anti-aging, recovery, performance or consumer claims.
Claims affected by this watchpoint
peptides
Does TB-500 speed injury recovery?
TB-500 injury-recovery claims are not supported by strong human clinical evidence.
Evidence:Early theoryRisk:High risk